TrovaGene Inc.

TrovaGene Inc.
Stock Exchange NASDAQ Stock Market
EPS
$8.49
Market Cap
$13.06 M
Shares Outstanding
5.42 M
Public Float
3.99 M

Profile

Address
11055 Flintkote Avenue
San Diego California 92121
United States
Employees -
Website http://www.trovagene.com
Updated 07/08/2019
Trovagene, Inc. is a clinical-stage, precision medicine oncology therapeutics company. Its focuses on developing PCM-075, is a Polo-like Kinase 1 (PLK1) selective adenosine triphosphate (ATP) competitive inhibitor. The company was founded by Gabriel M.

Financials

View All
Created with Highcharts 5.0.14TrovaGene Inc.Net Income. Fiscal year is January-December. All values USD Thousands.11 81011 81014 32514 32527 47127 47139 20339 20324 90624 90616 46116 461201320142015201620172018010k20k30k40k50k
Created with Highcharts 5.0.14TrovaGene Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.2592592802803123123813815055053783782013201420152016201720180100200300400500600

Thomas H. Adams
Chairman & Chief Executive Officer
Athena Countouriotis
Independent Director